BioHarvest Sciences Inc. (BHST)
NGM – Real vaqt narxi. Valyuta: USD
2.77
+0.01 (0.36%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
2.77
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:10 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
2.77
+0.01 (0.36%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
2.77
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:10 PM EDT
BioHarvest Sciences Inc. Isroil va Qo'shma Shtatlarda biotexnologiya kompaniyasi sifatida faoliyat yuritadi. U ikkita segment orqali faoliyat yuritadi: Mahsulotlar va CDMO xizmatlari. Kompaniya faol faol moddalarning yuqori konsentratsiyasiga ega o'simlik hujayralarini ishlab chiqarish uchun botanika sintez platformasi texnologiyasini ishlab chiqadi. Kompaniya sog'liq va farovonlik uchun ilmiy asoslangan nutriyent yechimlarni tadqiq qilish, ishlab chiqish, ishlab chiqarish, marketing va sotish bilan shug'ullanadi, ular parhez qo'shimchalari va funktsional oziq-ovqat va ichimliklar sifatida ishlab chiqariladi va sotiladi, shuningdek, sog'liq, farmatsevtika va kosmetika uchun ilmiy asoslangan yechimlarni ishlab chiqarish, marketing va sotish bilan shug'ullanadi. Kompaniya shuningdek, shartnoma asosida ishlab chiqish va ishlab chiqarish operatsiyalari xizmatlarini taqdim etadi. Bundan tashqari, u qizil uzum sharobida mavjud bo'lgan polifenollarning matritsasini o'z ichiga olgan qizil uzum hujayrasi parhez qo'shimchasi bo'lgan VINIAni taklif etadi. Kompaniya o'simlik asosidagi tatlandırıcı molekulalarni ishlab chiqish uchun Tate & Lyle plc bilan strategik hamkorlikka ega. Kompaniya Vankuverda, Kanadada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Ilana Belzer Ph.D. | Chief Operating Officer |
| Dr. Malkit Azachi Ph.D. | Vice President of Research & Development |
| Dr. Yoheved Hagay Ph.D. | Co-Founder & CTO |
| Dr. Zaki Rakib Ph.D. | Co-Founder, CEO, Executive Chairman & President |
| Jared Turner | Chief Sales Officer |
| Mr. David K. Ryan | VP of Investor Relations & Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-18 | 6-K | bhsc_6k.htm |
| 2026-05-28 | 6-K | bhsc_6k.htm |
| 2026-05-14 | 6-K | bhsc_6k.htm |
| 2026-05-13 | 6-K | bhsc_6k.htm |
| 2026-05-12 | 6-K | bhsc_6k.htm |
| 2026-05-11 | 6-K | bhsc_6k.htm |
| 2026-05-01 | 6-K | bhsc_6k.htm |
| 2026-04-29 | 6-K | bhsc_6k.htm |
| 2026-03-31 | 40-F | bhst-20251231_40f.htm |
| 2026-03-27 | 6-K | bhsc_6k.htm |
| Ms. Bar Dichter | Chief Financial Officer |
| Ms. Michal Abargel Sapir | Vice President of Regulatory Affairs |